Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119407) titled 'Optimization of an IBD Self-management Support App and Evaluation of Its Intervention Effect' on Feb. 26.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Affiliated Hospital of Zhejiang University
Condition:
Inflammatory bowel disease
Intervention:
Stage I - Control Group:Routine management with standard health education and guidance in outpatient or inpatient settings (adherence to prescribed medication, diet and exercise, follow-up visits, and warning signs), lasting 1 month.
Stage I - Trial Group:Routine management plus Chang Xiang Sui APP intervention (health educat...